Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Unlimited Watchlists, Portfolios, Screeners, and other Barchart tools. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Freeline Therapeutics Holdings Plc Adss (FRLN)

Freeline Therapeutics Holdings Plc Adss (FRLN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Freeline Therapeutics Holdings Plc Adss STEVENAGE BIOSCIENCE CATALYST TEVENAGE HERTFORDSHIRE X0 SG1 2FX GBR

P: 44-0-14-3890-6870

Description:

Freeline Therapeutics Holdings plc is a clinical-stage biotechnology company. It is focused on AAV-based gene therapy targeting the liver. The company operates principally in Germany and the U.S. Freeline Therapeutics Holdings plc is headquartered in the U.K.

Key Statistics

Overview:

Market Capitalization, $K 38,333
Enterprise Value, $K -79,327
Shares Outstanding, K 64,972
Annual Sales, $ 0 K
Annual Net Income, $ -140,390 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -14,890 K
60-Month Beta 0.18
% of Insider Shareholders 1.90%
% of Institutional Shareholders 58.48%
Float, K 63,738
% Float 98.10%
Short Volume Ratio 0.69

Growth:

1-Year Return -77.81%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.20 on 11/15/22
Next Earnings Date N/A
Earnings Per Share ttm -2.12
EPS Growth vs. Prev Qtr 37.50%
EPS Growth vs. Prev Year 76.74%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

FRLN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -101.38%
Return-on-Assets % -67.17%
Profit Margin % 0.00
Net Margin % N/A
Debt/Equity N/A
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.53
Book Value/Share 1.06
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar